Benzo[a]pyrene induces oxidative stress and endothelial progenitor cell dysfunction via the activation of the NF-κB pathway

International Journal of Molecular Medicine

Volumn 31, Issue 4, 2013, Pages 922-930

  Ji, Kangting ^a   Xing, Cheng ^a   Jiang, Fengchun ^a   Wang, Xiaoyan ^a   Guo, Huihui ^a   Nan, Jinliang ^a   Qian, Lu ^a   Yang, Penglin ^a   Lin, Jiafeng ^a   Li, Meide ^b   Li, Jinnong ^b   Liao, Lianming ^b   Tang, Jifei ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Atherosclerosis; Benzo a pyrene; Endothelial progenitor cell; Nuclear factor B; Reactive oxygen species; Smoking

Indexed keywords

BENZO[A]PYRENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMOKING; STRESS; UMBILICAL CORD BLOOD;

ANALYSIS OF VARIANCE; BENZO(A)PYRENE; CELL PHYSIOLOGICAL PROCESSES; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; OXIDATIVE STRESS; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875260058     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1288     Document Type: Article

References (45)

1. World Health Organisation Tobacco Free Initiative. Oslo, Norway: WHO Workshop on Advancing Knowledge on Regulating Tobacco Products, February 2000.
2. Rogot E and Murray JL: Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 95: 213-222, 1980.
3. Howard G, Wagenknecht LE, Burke GL, et al: Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 279: 119-124, 1998.
4. Jiang CQ, Xu L, Lam TH, Lin JM, Cheng KK and Thomas GN: Smoking cessation and carotid atherosclerosis: the Guangzhou Biobank Cohort Study-CVD. J Epidemiol Community Health 64: 1004-1009, 2010.
5. Rodgman A, Smith CJ and Perfetti TA: The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 19: 573-595, 2000.
6. Baird WM, Hooven LA and Mahadevan B: Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45: 106-114, 2005.
7. Shi Z, Dragin N, Miller ML, et al: Oral benzo[a]pyrene-induced cancer: two distinct types in different target organs depend on the mouse Cyp1 genotype. Int J Cancer 127: 2334-2350, 2010.
8. Griendling KK, Sorescu D and Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
9. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-S420, 1999.
10. Libby P: Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
11. Li DW, Liu ZQ, Wei J, Liu Y and Hu LS: Contribution of endothelial progenitor cells to neovascularization (Review). Int J Mol Med 30: 1000-1006, 2012.
12. Rabelink TJ, de Boer HC, de Koning EJ and van Zonneveld AJ: Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 24: 834-838, 2004.
13. Hristov M, Zernecke A, Bidzhekov K, et al: Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res100: 590-597, 2007.
14. Hutter R, Carrick FE, Valdiviezo C, et al: Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110: 2430-2435, 2004.
15. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003.
16. Ramos KS, Zhang Y, Sadhu DN and Chapkin RS: The induction of proliferative smooth muscle cell phenotypes by benzo[a]pyrene is characterized by up-regulation of inositol phospholipid metabolism and c-Ha-ras gene expression. Arch Biochem Biophys 332: 213-222, 1996.
17. Curfs DM, Lutgens E, Gijbels MJ, Kockx MM, Daemen M, and van Schooten FJ: Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol 164: 101-108, 2004.
18. Smaniotto S, Martins-Neto AA, Dardenne M and Savino W: Growth hormone is a modulator of lymphocyte migration. Neuroimmunomodulation 18: 309-313, 2011.
19. Kleinman HK and Martin GR: Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386, 2005.
20. Cominacini L, Garbin U, Pasini AF, et al: Oxidized low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine. J Hypertens 16: 1913-1919, 1998.
21. Heid CA, Stevens J, Livak KJ and Williams PM: Real time quantitative PCR. Genome Res 6: 986-994, 1996.
22. Gibson UE, Heid CA and Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001, 1996.
23. Ziegler-Heitbrock HW, Sternsdorf T, Liese J, et al: Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol 151: 6986-6993, 1993.
24. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
25. Hur J, Yoon CH, Kim HS, et al: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24: 288-293, 2004.
26. Grunewald M, Avraham I, Dor Y, et al: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124: 175-189, 2006.
27. Yamahara K and Itoh H: Potential use of endothelial progenitor cells for regeneration of the vasculature. Ther Adv Cardiovasc Dis 3: 17-27, 2009.
28. Sirker AA, Astroulakis ZM and Hill JM: Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci 116: 283-299, 2009.
29. Peichev M, Naiyer AJ, Pereira D, et al: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000.
30. Urbich C and Dimmeler S: Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353, 2004.
31. Salvatore P, Casamassimi A, Sommese L, et al: Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci USA 105: 9427-9432, 2008.
32. Asahara T and Kawamoto A: Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579, 2004.
33. Kamihata H, Matsubara H, Nishiue T, et al: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052, 2001.
34. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ and Verma S: Endothelial progenitor cells: new hope for a broken heart. Circulation 107: 3093-3100, 2003.
35. Werner N, Kosiol S, Schiegl T, et al: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005.
36. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res89: E1-E7, 2001.
37. Tepper OM, Galiano RD, Capla JM, et al: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786, 2002.
38. + cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 27: 2247-2255, 2006.
39. Heeschen C, Lehmann R, Honold J, et al: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622, 2004.
40. Cai H and Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
41. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
42. Pryor WA, Prier DG and Church DF: Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 47: 345-355, 1983.
43. Pryor WA, Stone K, Zang LY and Bermudez E: Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage. Chem Res Toxicol 11: 441-448, 1998.
44. Zang LY, Stone K and Pryor WA: Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 19: 161-167, 1995.
45. Haddad JJ: Oxygen sensing and oxidant/redox-related pathways. Biochem Biophys Res Commun 316: 969-977, 2004.